{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T22:52:27Z","timestamp":1763765547558},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2005,8,16]],"date-time":"2005-08-16T00:00:00Z","timestamp":1124150400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Colorectal Dis"],"published-print":{"date-parts":[[2006,5]]},"DOI":"10.1007\/s00384-005-0013-5","type":"journal-article","created":{"date-parts":[[2005,8,15]],"date-time":"2005-08-15T08:31:41Z","timestamp":1124094701000},"page":"365-372","source":"Crossref","is-referenced-by-count":7,"title":["Significant growth inhibition of orthotopic pancreatic ductal adenocarcinoma by CpG oligonucleotides in immunodeficient mice"],"prefix":"10.1007","volume":"21","author":[{"given":"J.","family":"Tepel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Dagvadorj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Kapischke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Sipos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Leins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Kremer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Kalthoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2005,8,16]]},"reference":[{"key":"13_CR1","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3322\/canjclin.53.1.5","volume":"53","author":"A Jemal","year":"2003","unstructured":"Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun MJ (2003) Cancer statistics 2003. CA Cancer J Clin 53:5\u201326","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"13_CR2","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/00000658-199502000-00003","volume":"221","author":"KD Lillemoe","year":"1995","unstructured":"Lillemoe KD (1995) Current management of pancreatic carcinoma. Ann Surg 221(2):133\u2013148","journal-title":"Ann Surg"},{"issue":"8","key":"13_CR3","first-page":"320","volume":"43","author":"O Ishikawa","year":"1996","unstructured":"Ishikawa O (1996) Surgical technique, curability and postoperative quality of life in an extended pancreatectomy for adenocarcinoma of the pancreas. Hepatogastroenterology 43(8):320\u2013325","journal-title":"Hepatogastroenterology"},{"issue":"3","key":"13_CR4","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1007\/s00268-002-6659-z","volume":"27","author":"A Richter","year":"2003","unstructured":"Richter A, Niedergethmann M, Sturm JW, Lorenz D, Post S, Trede M (2003) Long-term results of partial pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head: 25-year experience. World J Surg 27(3):324\u2013329","journal-title":"World J Surg"},{"issue":"Suppl 3","key":"13_CR5","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/(SICI)1097-0142(19960801)78:3+<580::AID-CNCR2>3.0.CO;2-F","volume":"78","author":"HJ Wanebo","year":"1996","unstructured":"Wanebo HJ, Vezeridis MP (1996) Pancreatic carcinoma in perspective. A continuing challenge. Cancer 78(Suppl 3):580\u2013591","journal-title":"Cancer"},{"issue":"21","key":"13_CR6","first-page":"855","volume":"45","author":"D Henne-Bruns","year":"1998","unstructured":"Henne-Bruns D, Vogel I, L\u00fcttges J, Kl\u00f6ppel G, Kremer B (1998) Ductal adenocarcinoma of the pancreas head: survival after regional versus extended lymphadenectomy. Hepatogastroenterology 45(21):855\u2013866","journal-title":"Hepatogastroenterology"},{"issue":"1","key":"13_CR7","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/1096-9098(200005)74:1<36::AID-JSO9>3.0.CO;2-F","volume":"74","author":"P Magistrelli","year":"2001","unstructured":"Magistrelli P, Antinore A, Crucitti A, La Greca A, Masetti R, Coppola R, Nuzzo G, Picciochi A (2001) Prognostic factors after surgical resection for pancreatic carcinoma. J Surg Oncol 74(1):36\u201340","journal-title":"J Surg Oncol"},{"key":"13_CR8","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/00000658-200301000-00011","volume":"237","author":"JE Lim","year":"2003","unstructured":"Lim JE, Chien MW, Earle CC (2003) Prognostic factors following curative resection for pancreatic adenocarcinoma. Ann Surg 237:74\u201385","journal-title":"Ann Surg"},{"issue":"Suppl","key":"13_CR9","first-page":"411","volume":"115","author":"M Trede","year":"1998","unstructured":"Trede M, Wendl K, Richter A (1998) Pancreatic carcinoma\u2014conclusions and prospects. Langenbeck's Arch Surg 115(Suppl):411\u2013442","journal-title":"Langenbeck's Arch Surg"},{"issue":"2","key":"13_CR10","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s002689900215","volume":"21","author":"C Sperti","year":"1997","unstructured":"Sperti C, Pasquali C, Piccoli A, Pedrazzoli S (1997) Recurrence after resection for ductal adenocarcinoma of the pancreas. World J Surg 21(2):195\u2013200","journal-title":"World J Surg"},{"issue":"2","key":"13_CR11","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0960-7404(10)80009-X","volume":"4","author":"DA Hunstad","year":"1995","unstructured":"Hunstad DA, Norton JA (1995) Management of pancreatic carcinoma. Surg Oncol 4(2):61\u201374","journal-title":"Surg Oncol"},{"key":"13_CR12","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/01.sla.0000097793.68830.5e","volume":"258","author":"RR White","year":"2003","unstructured":"White RR, Ashish SS, Douglas ST (2003) Pancreatic cancer since Hasted\u2014how far have we come and where are we going? Ann Surg 258:132\u2013147","journal-title":"Ann Surg"},{"key":"13_CR13","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1056\/NEJMoa032295","volume":"350","author":"JP Neoptolemos","year":"2004","unstructured":"Neoptolemos JP, Stocken DD, Friess H, Bassi C, Dunn JA, Hickey H, Beger H, Fernandez-Cruz L, Dervenis C, Lacaine F, Falconi M, Pederzoli P, Pap A, Spooner D, Kerr DJ, B\u00fcchler M (2004) A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med 350:1200\u20131210","journal-title":"N Engl J Med"},{"issue":"1","key":"13_CR14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00006676-200401000-00001","volume":"28","author":"J Tepel","year":"2004","unstructured":"Tepel J, Kruse M-L, March C, Fiedler A, Kapischke M, Ketterer T, Sipos B, Kremer B, Kalthoff H (2004) Terminally modified oligodeoxynucleotides directed against p53 in an orthotopic xenograft model: a novel adjuvant treatment strategy for pancreatic ductal carcinoma. Pancreas 28(1):1\u201312","journal-title":"Pancreas"},{"key":"13_CR15","first-page":"242","volume":"3","author":"J Tepel","year":"2003","unstructured":"Tepel J, Kruse M-L, March C, Dagvadorj, Kremer B, Kalthoff H (2003) EVITON\u2014a new DNA-based substance in a preclinical model of pancreatic carcinoma. Pancreatology 3:242 (Abstract)","journal-title":"Pancreatology"},{"key":"13_CR16","unstructured":"Tepel et al., in press"},{"issue":"16","key":"13_CR17","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.2174\/1381612013397249","volume":"7","author":"WW Leitner","year":"2001","unstructured":"Leitner WW, Hammerl P, Thalhammer J (2001) Nucleic acid for the treatment of cancer: genetic vaccines and DNA adjuvants. Curr Pharm Des 7(16):1641\u20131667","journal-title":"Curr Pharm Des"},{"issue":"11","key":"13_CR18","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1002\/1521-4141(200211)32:11<3235::AID-IMMU3235>3.0.CO;2-J","volume":"32","author":"K Heckelsmiller","year":"2002","unstructured":"Heckelsmiller K, Beck S, Rall K, Sipos B, Schlamp A, Tuma E, Rothenfusser S, Endres S, Hartmann G (2002) Combined dendritic cell- and CpG oligonucleotide-based immune therapy cures large murine tumors that resist chemotherapy. Eur J Immunol 32(11):3235\u20133245","journal-title":"Eur J Immunol"},{"key":"13_CR19","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1172\/JCI200419762","volume":"113","author":"K Furumoto","year":"2004","unstructured":"Furumoto K, Soares L, Engleman EG, Merad M (2004) Induction of potent antitumor immunity by in situ targeting of intratumoral DCs. J Clin Invest 113:774\u2013783","journal-title":"J Clin Invest"},{"issue":"3","key":"13_CR20","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1089\/108729001300338717","volume":"11","author":"AM Krieg","year":"2001","unstructured":"Krieg AM (2001) From bugs to drugs: therapeutic immunomodulation with oligodeoxynucleotides containing CpG sequences from bacterial DNA. Antisense Nucleic Acid Drug Dev 11(3):181\u2013188","journal-title":"Antisense Nucleic Acid Drug Dev"},{"issue":"3\u20134","key":"13_CR21","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1615\/CritRevEukarGeneExpr.v8.i3-4.70","volume":"8","author":"RA Perugini","year":"1998","unstructured":"Perugini RA, McDade TP, Vittimberga FJ Jr, Callery MP (1998) The molecular and cellular biology of pancreatic cancer. Crit Rev Eukaryot Gene Expr 8(3\u20134):377\u2013393","journal-title":"Crit Rev Eukaryot Gene Expr"},{"issue":"5","key":"13_CR22","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1007\/s00428-003-0784-4","volume":"442","author":"B Sipos","year":"2003","unstructured":"Sipos B, Moser S, Kalthoff H, Torok V, Lohr M, Kloppel G (2003) A comprehensive characterization of pancreatic ductal carcinoma cell lines: towards the establishment of an in vitro research platform. Virchows Arch 442(5):444\u2013452","journal-title":"Virchows Arch"},{"issue":"3","key":"13_CR23","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/BF00300234","volume":"24","author":"MM Tomayko","year":"1989","unstructured":"Tomayko MM, Reynolds CP (1989) Determination of subcutaneous tumor size in athymic (nude) mice. Cancer Chemother Pharmacol 24(3):148\u2013154","journal-title":"Cancer Chemother Pharmacol"},{"key":"13_CR24","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1007\/s004280100474","volume":"439","author":"PS Moore","year":"2001","unstructured":"Moore PS, Sipos B, Orlandini S, Sorio C, Real FX, Lemoine NR, Gress T, Bassi C, Kl\u00f6ppel G, Kalthoff H, Ungefroren H, L\u00f6hr M, Scarpa A (2001) Genetic profile of 22 pancreatic carcinoma cell lines. Analysis of K-ras, p53, p16 and DPC4\/Smad4. Virchows Arch 439:798\u2013802","journal-title":"Virchows Arch"},{"key":"13_CR25","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0304-3835(01)00420-7","volume":"165","author":"F Alves","year":"2001","unstructured":"Alves F, Borchers U, Padge B, Augustin H, Nebendahl K, Kl\u00f6ppel G, Tietze LF (2001) Inhibitory effect of a matrix metalloproteinase inhibitor on growth and spread of human pancreatic ductal adenocarcinoma evaluated in an orthotopic severe combined immunodeficient (SCID) mouse model. Cancer Lett 165:161\u2013170","journal-title":"Cancer Lett"},{"issue":"1","key":"13_CR26","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3109\/07388559609146601","volume":"16","author":"JS Sandhu","year":"1996","unstructured":"Sandhu JS, Boynton E, Gorczynski, Hozumi N (1996) The use of SCID mice in biotechnology and as a model for muhamn diseases. Crit Rev Biotechnol 16(1):95\u2013118","journal-title":"Crit Rev Biotechnol"},{"issue":"Suppl 2","key":"13_CR27","first-page":"95","volume":"81","author":"M Jacrot","year":"1994","unstructured":"Jacrot M (1994) Use of immunodeficient mice in experimental cancer research. Bull Cancer 81(Suppl 2):95\u201397","journal-title":"Bull Cancer"},{"key":"13_CR28","doi-asserted-by":"crossref","unstructured":"Leblond V, Autran B, Cesbron JY (1997) The SCID mouse mutant: definition and potential use as model for immune and haematological disorders. Curr Opin Hematol 6","DOI":"10.1007\/s00282-997-0213-2"},{"issue":"11","key":"13_CR29","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1034\/j.1600-0854.2000.011102.x","volume":"1","author":"DM Ward","year":"2000","unstructured":"Ward DM, Griffiths GM, Stinchcombe JC, Kaplan J (2000) Analysis of the lysosomal storage disease Chediak-Higashi syndrome. Traffic 1(11):816\u2013822","journal-title":"Traffic"},{"issue":"2","key":"13_CR30","first-page":"131","volume":"5","author":"RF Holcombe","year":"1994","unstructured":"Holcombe RF, Jones KL, Stewart RM (1994) Lysosomal enzyme activities in Chediak-Higashi syndrome: evaluation of lymphoid cell lines and review of the literature. Immunodeficiency 5(2):131\u2013140","journal-title":"Immunodeficiency"},{"key":"13_CR31","doi-asserted-by":"crossref","first-page":"4878","DOI":"10.4049\/jimmunol.167.9.4878","volume":"167","author":"ZK Ballas","year":"2001","unstructured":"Ballas ZK, Krieg A, Warren T, Rasmussen W, Davis HL, Waldschmidt M, Weiner GJ (2001) Divergent therapeutic and immunologic effects of oligodeoxynucleotides with distinct CpG motifs. J Immunol 167:4878\u20134886","journal-title":"J Immunol"},{"issue":"37","key":"13_CR32","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1055\/s-2001-17110","volume":"126","author":"A Krug","year":"2001","unstructured":"Krug A, Hartmann G (2001) Specific modification of the immune system with CpG-oligonucleotides. Dtsch Med Wochenschr 126(37):1002\u20131004","journal-title":"Dtsch Med Wochenschr"},{"issue":"Suppl 4","key":"13_CR33","first-page":"885","volume":"55","author":"RD McDermott-Lancaster","year":"1987","unstructured":"McDermott-Lancaster RD, Ito T, Kohaska K, Colston MJ (1987) The nude mouse\u2014characteristics, breeding and husbandry. Int J Lepr Other Mycobact Dis 55(Suppl 4):885\u2013888","journal-title":"Int J Lepr Other Mycobact Dis"},{"key":"13_CR34","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/nm987","volume":"10","author":"M Heikenwalder","year":"2004","unstructured":"Heikenwalder M, Polymenidou M, Junt T, Sigurdson C, Wagner H, Akira S, Zinkernagel R, Aguzzi A (2004) Lymphoid follicle destruction and immunosuppression after repeated CpG oligodeoxynucleotide administration. Nat Med 10:187\u2013192","journal-title":"Nat Med"},{"key":"13_CR35","doi-asserted-by":"crossref","first-page":"4531","DOI":"10.4049\/jimmunol.168.9.4531","volume":"168","author":"V Hornung","year":"2002","unstructured":"Hornung V, Rothenfusser S, Britsch S, Krug A, Jahrsdorfer B, Giese T, Endres S, Hartmann G (2002) Quantitative expression of Toll-like receptor 1\u201310 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J Immunol 168:4531","journal-title":"J Immunol"},{"issue":"8","key":"13_CR36","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1007\/s00535-003-1136-5","volume":"38","author":"JM Otte","year":"2003","unstructured":"Otte JM, Kiehne K, Herzig KH (2003) Antimicrobial peptides in innate immunity of the human intestine. J Gastroenterol 38(8):717\u2013726","journal-title":"J Gastroenterol"}],"container-title":["International Journal of Colorectal Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00384-005-0013-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00384-005-0013-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00384-005-0013-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,9]],"date-time":"2020-04-09T01:30:20Z","timestamp":1586395820000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00384-005-0013-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8,16]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,5]]}},"alternative-id":["13"],"URL":"https:\/\/doi.org\/10.1007\/s00384-005-0013-5","relation":{},"ISSN":["0179-1958","1432-1262"],"issn-type":[{"value":"0179-1958","type":"print"},{"value":"1432-1262","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,8,16]]}}}